相关视频 - | JoVE Visualize

Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

Search research articles

相关实验视频

Marianne Baastrup Søndergaard¹, Frederik Roager Madsen¹, Asger Sverrild¹

¹Lunge- og Infektionsmedicinsk Afdeling, Københavns Universitetshospital - Bispebjerg og Frederiksberg Hospital.

Ugeskrift for laeger

|April 12, 2024

概括

对于喘和COPD等阻塞性肺部疾病的治疗,通过吸入性皮质类固醇和生物药物取得了重大进展. 未来的护理将集中在针对严重病例的专门中心的个性化医疗上.

科学领域:

肺部病理学肺部病理学
呼吸系统医学呼吸系统医学

相关实验视频

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Severe asthma and remission prospects in Europe (SHARP): insights from a multicentre observational study based on the European Severe Asthma Registry.

The Lancet. Respiratory medicine·2026

Same author

From mild-to-moderate to severe asthma: Risk factors and patient profiles from the NORDSTAR cohort.

American journal of respiratory and critical care medicine·2026

Same author

Azithromycin enhances epithelial antiviral immunity in uncontrolled asthma: results from the AZIMUNE randomized controlled trial.

The European respiratory journal·2026

Same author

Five-year inhaled, systemic, and total corticosteroid exposure reduction during anti‒interleukin-5 receptor alpha treatment for severe asthma.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026

Same author

Dupilumab for Chronic Spontaneous Urticaria with Comorbid Type 2 Inflammatory Conditions: Case Report and Systematic Review of the Literature.

Case reports in dermatology·2026

Same author

Cumulative corticosteroid burden over 25 years in patients initiating biologic therapy for severe asthma: a nationwide cohort study.

ERJ open research·2026

临床治疗学临床治疗学

背景情况:

在过去的30年里,在治疗阻塞性肺部疾病方面取得了重大进展.
吸入性皮质类固醇 (ICS) 和生物治疗对喘和COPD护理的革命性影响.
生物疗法在严重喘中显示出高效,预计将被批准用于COPD.

结论:

未来严重阻塞性肺部疾病的管理可能需要专门的中心.
专注于个性化的方法和持续监测将定义先进的呼吸护理.
新型疗法和量身定制策略的整合有望改善喘和COPD患者的治疗结果.